Skip to search formSkip to main contentSkip to account menu

BMS 777607

Known as: BMS-777607, BMS777607, MET Tyrosine Kinase Inhibitor BMS-777607 
An inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS-777607 binds to c-Met protein, or… 
National Institutes of Health

Related topics

Related topics

1 relation
Receptor Tyrosine Kinase Inhibition

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A C-Met chemical inhibitor promotes fracture healing through interacting with osteogenic differentiation via the mTORC1 pathway.
2018
2018
Abstract A30: Ron kinase inhibition to improve immunotherapy for breast cancer metastasis
Metastasis is the cause of death for nearly all types of cancer, including breast cancer. An exciting new area of research in… 
Review
2016
Review
2016
Kidney cancer: Exosome transmission of sunitinib resistance
carcinoma (RCC) can be mediated by a long noncoding RNA (lncRNA) and this resistance can be transmitted between cells via… 
2016
2016
Design, synthesis and biological evaluation of c-Met kinase inhibitors bearing 2-oxo-1,2-dihydroquinoline scaffold.
2014
2014
BMS-777607 promotes megakaryocytic differentiation and induces polyploidization in the CHRF-288-11 cells
Introduction of a polyploidy inducer is a promising strategy to achieve a high level of polyploidization during megakaryocytic… 
2014
2014
Discovery of Novel c-Met Inhibitors Bearing a 3-Carboxyl Piperidin-2-one Scaffold
A series of compounds containing a novel 3-carboxypiperidin-2-one scaffold based on the lead structure BMS-777607 were designed… 
2014
2014
Activation of HER 3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors : Suggestion of Combination Therapy 1
The Axl receptor tyrosine kinase (RTK) has been established as a strong candidate for targeted therapy of cancer. However, the… 
2013
2013
New aminopyrimidine derivatives as inhibitors of the TAM family.
2013
2013
86 Evaluating BMS-777607 as a candidate therapeutic agent in malignant pleural mesothelioma
2008
2008
569 POSTER Preclinical studies and characterization of BMS-777607, a small molecule inhibitor of Met receptor tyrosine kinase
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)